Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

16.14USD
22 Mar 2019
Change (% chg)

$-1.62 (-9.12%)
Prev Close
$17.76
Open
$17.61
Day's High
$17.65
Day's Low
$16.13
Volume
295,189
Avg. Vol
270,194
52-wk High
$19.11
52-wk Low
$8.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 1.66 -0.248
Sep '18 1.03 -0.310
Jun '18 1.03 -0.370
Mar '18 1.03 -0.268
FY 2017 Dec '17 1.03 -0.286
Sep '17 1.03 -0.258
Jun '17 1.03 -0.233
Mar '17 1.03 -0.245
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 6 2.39 5.65 0.90 1.01
Quarter Ending Jun-19 6 1.23 2.40 0.15 0.75
Year Ending Dec-19 6 5.80 9.00 1.35 1.91
Year Ending Dec-20 5 8.50 16.91 4.10 24.58
Earnings (per share)
Quarter Ending Mar-19 7 -0.23 -0.17 -0.26 -0.25
Quarter Ending Jun-19 7 -0.26 -0.17 -0.29 -0.26
Year Ending Dec-19 7 -1.05 -0.69 -1.20 -1.02
Year Ending Dec-20 7 -1.04 -0.47 -1.52 -1.06
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 81.08 65.50 30.34
EPS (TTM) % 10.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Fate Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -3.45 39 --
13 Week 21.53 15.62 74 --
26 Week -0.48 -8.05 51 --
52 Week 38.72 17.58 72 --
YTD 64.14 44.15 78 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 96.73%
# of Holders: 169
Total Shares Held: 62,875,050
3 Mo. Net Change: 4,928,008
# New Positions: 30
# Closed Positions: 27
# Increased Positions: 102
# Reduced Positions: 62
# Net Buyers: 40
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.